For: | Bo XW, Sun LP, Yu SY, Xu HX. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions. World J Gastrointest Oncol 2021; 13(10): 1397-1411 [PMID: 34721773 DOI: 10.4251/wjgo.v13.i10.1397] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i10/1397.htm |
Number | Citing Articles |
1 |
Qing Zhao, Jing Wang, Yi‐li Fu, Bin Hu. Radiofrequency ablation for stage <IIB non‐small cell lung cancer: Opportunities, challenges, and the road ahead. Thoracic Cancer 2023; 14(32): 3181 doi: 10.1111/1759-7714.15114
|
2 |
Weijun Wan, Danxia Guo, Tong Kang, Jinshu Pang, Yunjing Pan, Jiamin Chen, Wei Liao, Yuji Chen, Peng Lin, Lipeng Li, Hong Yang, Yun He. Exploring the impact of insufficient thermal ablation on hepatocellular carcinoma: NDST2 overexpression mechanism and its role in facilitating growth and invasion of residual cancer cells. International Journal of Hyperthermia 2024; 41(1) doi: 10.1080/02656736.2024.2353309
|
3 |
Wenjing Lou, Liting Xie, Lei Xu, Min Xu, Fan Xu, Qiyu Zhao, Tianan Jiang. Present and future of metal nanoparticles in tumor ablation therapy. Nanoscale 2023; 15(44): 17698 doi: 10.1039/D3NR04362B
|
4 |
Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, Andries E. Braat, A. Stijn L. P. Crobach, Otto M. van Delden, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W. van der Meer, J. Frank W. Nijsen, Carla S. P. van Rijswijk, Joey Roosen, Bastian N. Ruijter, Frits Smit, Mette K. Stam, R. Bart Takkenberg, Maarten E. Tushuizen, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Mark C. Burgmans. Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial). CardioVascular and Interventional Radiology 2022; 45(8): 1057 doi: 10.1007/s00270-022-03162-7
|
5 |
Zhou Tian, Baojian Hong, Jianzhong Chen, Zhe Tang. Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.891724
|
6 |
Xinhang Hu, Qikang Hu, Yu He, Xuyang Yi, Zeyu Wu, Huali Hu, Yifan Ouyang, Fenglei Yu, Muyun Peng. Efficacy and safety of microwave ablation and its synergistic potential in the treatment of early-stage non-small cell lung cancer. Clinical Imaging 2024; 107: 110070 doi: 10.1016/j.clinimag.2023.110070
|
7 |
Fred G. Karaisz, Osama O. Elkelany, Benjamin Davies, Gerard Lozanski, Somashekar G. Krishna. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions. Diagnostics 2023; 13(3): 536 doi: 10.3390/diagnostics13030536
|
8 |
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami. Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 2023; 15(9): 2624 doi: 10.3390/cancers15092624
|
9 |
Xiuli Jin, Shuairan Zhang, Ningning Wang, Lin Guan, Chuanli Shao, Yingbo Lin, Jianping Liu, Yiling Li. High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.861601
|
10 |
Roberto Montalti, Gianluca Cassese, Ahmed Zidan, Gianluca Rompianesi, Mariano Cesare Giglio, Silvia Campanile, Lorenza Arena, Marco Maione, Roberto I. Troisi. Local recurrence risk factors and outcomes in minimally invasive thermal ablation for liver tumors: a single-institution analysis. HPB 2024; 26(5): 682 doi: 10.1016/j.hpb.2024.01.013
|